Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P030053/S093

MemoryGel Breast Implants

Mentor Corp. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONP030053/S093

What did the FDA decide?

This 30-day notice for PMA supplement P030053/S093 records a process change for MemoryGel breast implants. The stated change is the addition of small size packaging tooling on the existing packaging equipment. The supplement type is a process change involving manufacturer, sterilizer, packager, or supplier.

The decision field is OK30, and the supplement reason is listed as Process Change - Manufacturer/Sterilizer/Packager/Supplier. The device is a noninflatable, internal, silicone gel-filled breast prosthesis under product code FTR. The notice does not state a new indication, clinical data, or safety or effectiveness findings. Specific information about the tooling dimensions, affected package sizes, or validation results is absent from the supplied fields.

FDA approval order statement

the addition of small size packaging tooling on the existing packaging equipment
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
General, Plastic Surgery
Decision date
Oct 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P030053/S093
Regulatory pathway
PMA supplement
Applicant
Mentor Corp.
Product code
FTR
Decision code
OK30
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.

Applicant
Mentor Corp.
Product code
FTR
FDA device class
3

For the original device and its historical approval scope, see PMA P030053. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P030053 · Original PMA

    MEMORYGEL SILICONE GEL -FILLED BREAST IMPLANTS

  2. P030053/S093 received

    Application receipt date recorded by FDA.

  3. P030053/S093 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P030053. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030053

Product / regulatory recordCompanyPathwayDecision dateSource
Mentor Corp.PMA approvalNov 17, 2006FDA

Explore the linked device profile

Other records with product code FTR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Mentor Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
33 Technology Dr., Irvin, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records